Monitoring Electroconvulsive Therapy-Related Anxiety: The ECT-Related Anxiety Questionnaire.


Journal

The journal of ECT
ISSN: 1533-4112
Titre abrégé: J ECT
Pays: United States
ID NLM: 9808943

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 3 3 2020
medline: 17 7 2021
entrez: 3 3 2020
Statut: ppublish

Résumé

A reliable questionnaire designed to measure electroconvulsive therapy (ECT)-related anxiety is currently not available. We report the development and evaluation of the ECT-Related Anxiety Questionnaire (ERAQ), a questionnaire that measures anxiety with respect to ECT in clinical practice. Patients 18 years or older who were about to start with or were having an ECT course were asked to complete a self-designed 17-item ECT-related anxiety questionnaire. We investigated the psychometric properties of the ERAQ through the use of an exploratory and confirmatory factor analysis and Item Response Theory analysis. One hundred eighty-three patients were included. From the exploratory factor analysis, we conclude that the scale is unidimensional. The confirmatory factor analysis model did not fit well to the data. The Item Response Theory analysis showed that the slope estimates ranged from 1.23 to 2.95 and that location parameters reflected a sizable underlying anxiety for ECT. The ERAQ is a questionnaire that assesses ECT-related anxiety. It offers a measure of global severity and differentiates between various topics of anxiety. The ERAQ thus informs the clinician about the specific aspects of an ECT course that could trigger a patient's anxiety and can guide clinicians in how to discuss ECT-related anxieties with patients.

Identifiants

pubmed: 32118688
doi: 10.1097/YCT.0000000000000661
pii: 00124509-202009000-00009
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-186

Références

Sienaert P. What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist. Can J Psychiatry. 2011;56:5–12.
Sadowsky J. Electroconvulsive Therapy in America. The Anatomy of a Medical Controversy. New York, NY: Routledge; 2017.
Ayd FJ Jr. Chlorpromazine therapy for anxiety associated with electroshock therapy. Confin Neurol. 1956;16:168–173.
Freeman CPL, Kendell RE. Patients' experience and attitudes to electroconvulsive therapy. Br J Psychiatry. 1980;137:8–16.
Fox HA. Patients' fear of and objection to electroconvulsive therapy. Hosp Community Psychiatry. 1993;44:357–360.
Friedman MH. Fear of electroconvulsive therapy: notes from a patient's diary. Arch Neurol Psychiatry. 1957;78:385–391.
Sienaert P. Based on a true story? The portrayal of ECT in international movies and television programs. Brain Stimul. 2016;9:882–891.
Obbels J, Verwijk E, Bouckaert F, et al. ECT-related anxiety: a systematic review. J ECT. 2017;33:229–235.
Maranets I, Kain ZN. Preoperative anxiety and intraoperative anesthetic requirements. Anesth Analg. 1999;89:1346–1351.
Lautenschlager GJ, Meade AW, Kim SH. Cautions Regarding Sample Characteristics When Using the Graded Response Model. Paper presented at the 21st Annual Conference of the Society for Industrial and Organizational Psychology; Dallas; April 5–7, 2006.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Press; 2000.
Edelen MQ, Reeve BB. Applying Item Response Theory (IRT) modeling to questionnaire development, evaluation, and refinement. Qual Life Res. 2007;16:5–18.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: Foundation for Statistical Computing; 2013.
Psych: Procedures for Personality and Psychological Research. Evanston, IL: Northwestern University; 2017.
Rosseel Y. Lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48:1–36.
Rizopoulos D. Ltm: an R package for latent variable modelling and Item Response Theory analyses. J Stat Softw. 2006;17:1–25.
Embretson SE, Reise SP. Item Response Theory for Psychologists. Mahwah, NJ: Lawrence Erlbaum Associates; 2000.
Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, eds. Testing Structural Equation Models. Thousand Oaks, CA: Sage Publications; 1993:136–162.
Hu LT, Bentler PM. Cutoff criteria for fit indices in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6:1–55.
Guttman L. Some necessary conditions for common-factor analysis. Psychometrika. 1954;19:149–161.
Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas. 1960;20:141–151.
Brouwne MW. A note on Guttman's lower bound for the number of common factors. Psychometrika. 1968;33:223–236.
Gomez J. Subjective side-effects of ECT. Br J Psychiatry. 1975;127:609–611.
Malcolm K. Patients' perceptions and knowledge of electroconvulsive therapy. Psychiatr Bull. 1989;13:161–165.
Walter G, Koster K, Rey JM. Electroconvulsive therapy in adolescents: experience, knowledge, and attitudes of recipients. J Am Acad Child Adolesc Psychiatry. 1999;38:594–599.
Ejaredar M, Hagen B. All I have is a void: women's perceptions of the benefits and side effects of ECT. Int J Risk Saf Med. 2013;25:145–154.
Rose D, Fleischmann P, Wykes T, et al. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ. 2003;326:1363–1368.
Talbot K. ECT: exploring myths, examining attitudes. J Psychosoc Nurs Ment Health Serv. 1986;24:6–11.
Dillon P. Electroconvulsive therapy patient/family education. Convuls Ther. 1995;11:188–191.
Harrison B, Kaarsemaker B. Continuous quality improvements to an electroconvulsive therapy delivery system. J Psychosoc Nurs Ment Health Serv. 2000;38:27–35.
Payne NA, Prudic J. Electroconvulsive therapy part II: a biopsychosocial perspective. J Psychiatr Pract. 2009;15:369–390.
Ghaziuddin N, Walter G. Electroconvulsive Therapy in Children and Adolescents. New York, NY: Oxford University Press; 2013.

Auteurs

Jasmien Obbels (J)

From the KU Leuven-University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium.

Koen Vanbrabant (K)

From the KU Leuven-University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium.

Kristof Vansteelandt (K)

From the KU Leuven-University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium.

Pascal Sienaert (P)

From the KU Leuven-University of Leuven, University Psychiatric Center KU Leuven, Academic Center for ECT and Neuromodulation (AcCENT), Kortenberg, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH